Skip to main content
Experimental & Molecular Medicine logoLink to Experimental & Molecular Medicine
. 2009 Mar 31;41(3):140–150. doi: 10.3858/emm.2009.41.3.017

Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

Yan-Su Guo 1,2, Dong-Xia Wu 1,2, Hong-Ran Wu 1,2, Shu-Yu Wu 1,2, Cheng Yang 1,2, Bin Li 1, Hui Bu 1,2, Yue-sheng Zhang 3, Chun-Yan Li 1,2,
PMCID: PMC2679239  PMID: 19293633

Abstract

A subset of patients of amyotrophic lateral sclerosis (ALS) present with mutation of Cu/Zn superoxide dismutase 1 (SOD1), and such mutants caused an ALS-like disorder when expressed in rodents. These findings implicated SOD1 in ALS pathogenesis and made the transgenic animals a widely used ALS model. However, previous studies of these animals have focused largely on motor neuron damage. We report herein that the spinal cords of mice expressing a human SOD1 mutant (hSOD1-G93A), besides showing typical destruction of motor neurons and axons, exhibit significant damage in the sensory system, including Wallerian-like degeneration in axons of dorsal root and dorsal funiculus, and mitochondrial damage in dorsal root ganglia neurons. Thus, hSOD1-G93A mutation causes both motor and sensory neuropathies, and as such the disease developed in the transgenic mice very closely resembles human ALS.

Keywords: amyotrophic lateral sclerosis, mutation, nerve degeneration, spinal cord, spinal nerve roots, superoxide dismutase 1

Introduction

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive and fatal neurodegenerative disease. The hallmark of ALS is selective loss of motor neurons in the spinal cord, brainstem and cerebral cortex, resulting in muscle weakness and atrophy throughout the body. However, sensory neuropathy, including axonal loss in sensory nerve biopsy, abnormalities in somatosensory evoked potentials, reduced spinal cord conduction velocity, diminished vibration sense and/or abnormal touch-pressure sensation were also detected in up to 23% ALS patients (Dyck et al., 1975; Georgesco et al., 1994; Matsumoto et al., 1999; Isaacs et al., 2007; Pugdahl et al., 2007), implying that ALS is a multi-system neurodegenerative disease. Family history is indicated in 5~10% cases, but the sporadic and familial cases are clinically indistinguishable (Andersen, 2006), suggesting similar underlying mechanisms of neurodegeneration. Of the familial cases, about 20% present mutations in the gene that codes the cytosolic Cu/Zn superoxide dismutase 1 (hSOD1) (Rosen et al., 1993). Many of the hSOD1 mutants retain the enzymatic activity, but expression of such a mutant caused apoptosis in cultured neural cells and ALS-like disorder in animals while expression of the wild-type hSOD1 was not harmful (Gurney et al., 1994; Rabizadeh et al., 1995; Tu et al., 1996), although one study reported that expressing high levels of wild-type hSOD1 in mice was also mildly toxic to motor neurons (Jaarsma et al., 2000). These and other similar studies have led to the widely held belief that SOD1 mutation plays a major role in the pathogenesis of at least some familial ALS in humans. The mechanism by which mutant hSOD1 causes motor neuron death remains poorly understood. Interestingly, sensory impairment was also detected in a patient of familial ALS with a missense mutation (Gly93→Ser) in exon 4 of hSOD1 (Kawata et al., 1997).

Because expression of a hSOD1 mutant in animals develops an adult-onset and progressive loss of motor function and motor neurons, these transgenic animals have become a widely used ALS model. However, previous studies of these animals have focused largely on the motor system. Although degeneration of spinal cord DR axons in these animals has been mentioned in several previous reports (Sun et al., 2002; Fischer et al., 2005), detailed study about the damages in the sensory neurons and axons has not been reported. In view of the presence of sensory neuropathy in a large number of ALS patients, information on the sensory system of these mice is scarce but important. In the present study we have investigated the potential alterations of spinal cord sensory neurons and axons in transgenic mice expressing a hSOD1 mutant.

Results

The present study was performed in transgenic mice expressing a hSOD1 mutant where two adjacent nucleotides of exon 4/codon 93 of SOD1 were mutated resulting in replacement of glycine by alanine (hSOD1-G93A), which occurs in some familial ALS patients (Rosen et al., 1993). Non-transgenic littermates were used as a control. The histopathological examinations were focused on the lumbar region of the spinal cord (see Figure 1 for specific areas examined), since loss of motor neurons in ALS is most prominent in this region.

Figure 1.

Figure 1

Areas of spinal cord, including dorsal funiculus (DF), dorsal horn (DH), dorsal root (DR), dorsal root ganglia (DRG), ventral horn (VH) and ventral root (VR).

Progressive motor deficit and loss of motor neurons in hSOD1-G93A mice

The hSOD1-G93A mice began to show tremor in one or both hind limbs at 90~100 days of age and then presented progressive loss of motor functions, as indicated by gait abnormality and failure to extend a limb while being held in the air by their tails. These abnormalities were accompanied by muscle atrophy and loss of muscle strength. The animals became moribund at 131.3 ± 9.4 and 137.8 ± 11.9 days of age for male and female mice respectively (mean ± SD, n = 18-19): severe paralysis (failure to right itself within 30 seconds when placed on its side) and loss of up to 40% of their body weight. The age difference in reaching the moribund state between the male and female mice was not statistically significant. The animals were euthanized when reaching the moribund state, which is referred to as end stage throughout this report. Moreover, the number of ventral horn motor neurons in the spinal cords of hSOD1-G93A mice at end stage decreased 61.8%, compared with that in the littermates (Table 1). In contrast, no abnormalities were observed in the non-transgenic littermates during the same experimental period. These results confirm the presence of motor neuron degeneration in the hSOD1-G93A mice and are consistent with previous findings (Gurney et al., 1994; Feeney et al., 2001; Zang and Cheema, 2002). The number of dorsal horn sensory neurons in SOD1-G93A mice was not significantly different from that in their non-transgenic littermates (Table 1), consistent with the prevailing view that expression of hSOD1-G93A causes motor neuron disease.

Table 1.

Number of spinal cord neurons in mice with and without expression of hSOD1-G93A.

graphic file with name emm-41-140-i001.jpg

Lumbar enlargements were harvested from hSOD1-G93A mice at end stage and their non-transgenic littermates at the same age. There were 3 animals in each group and 12~15 sections were counted from each animal. Transversal sections (20 µm) were cut on a Leica VT 1000S vibratome. Motor neurons and sensory neurons were identified by immunohistochemical staining with SMI-32 and calretinin respectively. SMI-32-stained neurons in the ventral horn with a diameter of ≥25 µm were counted as motor neurons. Calretinin-positive neurons in the dorsal horn were counted as sensory neurons. Each value is a mean ± SD. *P < 0.05 vs Littermate.

Damage of both ventral and dorsal roots in hSOD1-G93A mouse spinal cord

The ventral root (VR) derives from ventral horn motor neurons, whereas the dorsal root (DR) derives from sensory neurons in DRG (Figure 1). A previous study showed that both fast and slow axonal transports were impaired in the VR of hSOD1-G93A mice (Zhang et al., 1997). We observed extensive and severe degeneration of VR in hSOD1-G93A mice at end stage, but not in the non-transgenic littermates at similar age (Figure 2). Similar changes also occurred in the DR of hSOD1-G93A mice, although perhaps somewhat less profound (Figure 2). In the semithin sections (1 µm) stained by toluidine blue, different stages of axonal disintegration could be observed in the transverse sections of both VR (Figure 2B and C) and DR (Figure 2B1 and C1). The density of myelinated nerve fibers was greatly reduced (Table 2). In the longitudinal sections, similar as seen in the transverse sections, the number of myelinated nerve fibers was greatly decreased. Wallerian-like degeneration was universal. Some myelin sheath formed bead-like ovoids (indicated by arrows in Figure 2D and D1). Moreover, degraded myelin debris appeared to be sequestered in phagocytes (indicated by the asterisks in Figure 2D and D1), suggesting that these cells might be assuming the debris-clearing task.

Figure 2.

Figure 2

Semithin sections showing degeneration of VR and DR in hSOD1-G93A mice. Tissues stained with Toluidine blue were obtained from hSOD1-G93A mice at end stage and their non-transgenic littermates at the same age. A-D was from VR and A1-D1 from DR. Many degenerated nerve fibers were observed in both VR and DR, and density of myelinated nerve fibers were reduced, especially in the VR. Arrows point to bead-like ovoid formed by degradated myelin sheath, and asterisks indicate macrophage-like cells (D and D1). The data are representative of all animals examined, at least 3 animals in each group. A, B, A1, and B1: 200×; C, D, C1, and D1: 400×.

Table 2.

Number of ventral and dorsal root axons.

graphic file with name emm-41-140-i002.jpg

Number of total and degenerated myelinated axons in the lumbar ventral and dorsal root were counted at 400× visual field on toluidine blue stained semi-thin sections (n = 3 fields from 3 mice). Number of total and degenerated VR and DR myelinated axons in G93A at 60d, 120d and end stage (End) were compared with their littermates respectively. Each value is a mean ± SD. *, P < 0.05.

Using the teasing fiber method, nerve fibers in the VR and DR of non-transgenic littermates were shown to possess intact myelin sheath (lateral and dense color) and axon (central and light color) with uniform diameter within each fiber and normal internodes (Figure 3A and A1). In contrast, Wallerian-like degeneration (discontinuous and/or swollen axons, and fragmented myelin sheath) was seen in both VR and DR of hSOD1-G93A mice (Figure 3B and B1). Different stages of degeneration of myelinated fibers were present, with some fibers forming bead-like structures and others collapsing into myelin ovoid or debris. Displayed by the Naumenko-Feigin silver staining, the axons in the VR and DR of non-transgenic littermates were continuous and uniform in caliber (Figure 3C and C1), whereas the axons in these regions of hSOD1-G93A mice were swollen and disintegrated (Figure 3D and D1). Furthermore, because some of the above results suggested that macrophages might be involved in the axonal damage (Figure 2D and D1), we performed immunohistochemical staining of CD68, which is a glycoprotein and is specifically expressed on macrophages. There were many CD68-positive spots (cells) in the VR and DR of hSOD1-G93A mice (Figure 3F and F1), whereas it was negative (only background staining) in the tissues of non-transgenic littermates (Figure 3E and E1). This finding strongly suggests that macrophages are indeed involved in the axonal degeneration.

Figure 3.

Figure 3

A, A1, B and B1: teased fibers, showing Wallarian-like degeneration in VR and DR of hSOD1-G93A mice at end stage. Arrows indicate Wallerian-like degeneration of myelinated nerve fibers forming ovoids. 400×. C, C1, D and D1: Naumenko-Feigin silver stain. Arrows point to degenerating axons in VR and DR of hSOD1-G93A mice at end stage. 400×. E, E1, F and F1: immunohistochemical staining of CD68. Arrows indicate CD68 positive cells between the nerve fibers of VR and DR of hSOD1-G93A mice at end stage. 400×. The data are representative of all animals examined, at least 3 animals in each group.

While the transmission electron micrographs of VR and DR of non-transgenic littermates showed a relatively homogenous axoplasm and intacted myelin sheath (Figure 4A and A1), the axoplasm of VR and DR of hSOD1-G93A was occupied by vacuoles and swollen mitochondria (Figure 4B and B1) and accompanied by degenerated and disappeared axons, myelin sheath collapsed and degradated into ovoids (Figure 4C, C1 and D1). In a few of cases, the axons were occupied completely or partly by a cell resembling a macrophage (Figure 4D). It was notable that these types of changes occurred in both VR and DR.

Figure 4.

Figure 4

Transmission electron microscopic examination on VR and DR of hSOD1-G93A mice and their littermates. 4000×. A and A1: normal axon and myelin sheath. B and B1: showing numerous vacuoles and swollen mitochondria in the axoplasm; C, C1 and D1: indicating collapse and degradation of myelin sheath with condensed or absent axon in the central part; D shows a macrophage-like cell within the myelin sheath occupying the axon. The data are representative of all animals examined, at least 3 animals in each group.

Damage of DRG neurons

Because the axons in DR were significantly damaged in hSOD1-G93A mice, we next examined the neurons in DRG. There did not appear to be a clear decrease in the number of DRG neurons in hSOD1-G93A mice (Figure 5A and B), based on the comparison of multiple sections of DRG from both hSOD1-G93A mice and their non-transgenic littermates. However, numerous vacuoles existed in many DRG neurons of hSOD1-G93A mice but not in those of the control animals (Figure 5C and D). Moreover, numerous DRG neurons of hSOD1-G93A mice showed swollen mitochondria under transmission electron microscope (Figure 5E and F), further documenting degeneration of these neurons.

Figure 5.

Figure 5

DRG degeneration in hSOD1-G93A mice. Tissues were obtained from hSOD1-G93A mice at end stage and their non-transgenic littermates at the same age. A-D: Toluidine blue staining. A and B: 100×; C and D: 400×. E and F: transmission electron microscopy. Arrows indicate swollen mitochondria in the DRG neurons of hSOD1-G93A mice. 15,000×.

Degeneration of dorsal funiculus (DF)

In addition to the damage of DR and DRG, hSOD1-G93A mice also exhibited severe DF degeneration. Staining the tissue sections with monoclonal antibody SMI-31, which recognizes phosphorylated neurofilaments, revealed extensive and severe loss of phosphorylated neurofilaments in DF, mainly in Region I (Figure 6A and C). Staining the tissue sections with toluidine blue showed the presence of numerous dense deposits in Region I of hSOD1-G93A mice (Figure 6B and D), which under high magnification were seen as decomposed nerve fibers with the normal ring-like myelin sheath and the central axon (Figure 6EI-III) being replaced by dense spheroids (Figure 6FI). Under transmission electron microscope, the dense spheroids showed by toluidine staining were verified as disintegrated myelin sheaths with the central axon disappeared. There were still many axons represented as high-electron density with their myelin sheaths collapsed more or less (indicated as asterisks in Figure 6GI). Region II and III were mostly uninvolved with only several degenerated nerve fibers sparsely distributed (Figure 6FII-III, 6GII-III).

Figure 6.

Figure 6

DF degeneration in hSOD1-G93A mice. Tissues were obtained from hSOD1-G93A mice at end stage and their non-transgenic littermates at the same age. A-D: 100×; E and F: 400×. G: 4000×. A and C: immunohistochemical staining with SMI-31. Asterisks show spongy degeneration of DF in hSOD1-G93A mice. B, D, E and F: toluidine blue staining. G: transmission electron microscopy. Arrows show disaggregated myelin sheath forming ovoids with the central axons disappeared. Asterisks indicate electron-densed axons in DF of hSOD1-G93A mice. The data are representative of all animals examined, at least 3 animals in each group.

Time course of neuronal damage

hSOD1-G93A mice showed their first sign of disease (limb tremor) at 90~100 days of age, and became moribund at 131~138 days of age, which was associated with profound degeneration of VR, DR and DF, as described before. However, histological features of degeneration in VR, DR and DF were visible as early as 60 days of age, and the degeneration deteriorated progressively thereafter (Figure 7). Thus, histological abnormalities occurred long before the animals showed any signs of disease. The neurons in DRG were not examined at the early time points, because we did not detect a significant loss of neurons at end stage.

Figure 7.

Figure 7

Time course of degeneration of VR, DR and DF in hSOD1-G93A mice. Tissues were obtained from hSOD1-G93A mice at indicated ages and from their non-transgenic littermates at 120 days of age and stained with toluidine blue. The data are representative of all animals examined, at least 3 animals in each group at each time point. A-I: 400×.

Discussion

Transgenic mice and rats expressing mutated human SOD1 develop an ALS-like disorder and have been widely used as ALS models. Our present study shows that expression of hSOD1-G93A in mice causes damage to spinal cord sensory neurons and axons in addition to causing damage to motor neurons and axons. This is significant, because several reports have shown the impairment of the sensory nervous system in a significant percentage of ALS patients (Dyck et al., 1975; Georgesco et al., 1994; Kawata et al., 1997; Matsumoto et al., 1999; Pugdahl et al., 2007). Although degeneration of spinal cord DR axons in these animals was briefly noted in several previous reports (Gurney et al., 1994; Fischer et al., 2005), the present study provides new and detailed information about the damages in the sensory neurons and axons and compared these damages to those in motor neurons and axons, as discussed below. Moreover, our present findings appear to contradict an existing hypothesis that motor neuron degeneration in hSOD1-G93A mice begins at muscle and distal axons and proceeds in a "dying back" manner (Fischer et al., 2004; Kraft et al., 2007), because such a mechanism does not explain the parallel degeneration occurring in the sensory neurons and axons.

We focused the current study on the lumbar region of the spinal cord, since clinical presentation of hSOD1-G93A transgenic mice was primarily associated with motor neuron degeneration in this region. The animals at the end stage showed marked loss of ventral horn motor neurons and extensive damage in VR, DR, DRG and DF, among which VR damage was the most pronounced. Interestingly, the dorsal horn neurons were largely spared. The reason for the resistance of these neurons to the toxic effect of hSOD1-G93A is unknown.

Further examination of VR, DR and DF showed that tissue damage was already visible at 60 days of age, long before the animals showed any signs of disease, and VR damage was again the most evident (Figure 7).

The VR fibers originate from ventral horn motor neurons, whereas the DR fibers originate from DRG sensory neurons. Previous studies have shown that mitochondrial damage and caspase-mediated apoptosis of spinal cord motor neurons play an important role in motor neuron degeneration in hSOD1-G93A mice (Li et al., 2000; Inoue et al., 2003). We have shown some similar changes in DRG neurons, including cytoplasmic vacuolation, and mitochondrial swelling (Figure 5). In this connection, it is worth noting that a previous study showed increased number of inclusion bodies in DRG neurons of sporadic ALS patients (Sasaki et al., 2007). The VR and DR fibers exhibited Wallerian-like degeneration: axon damage, myelin degeneration, and phagocytic cell (macrophages) infiltration into the tissues (Figure 2). Tissue infiltration of macrophages was further confirmed by the presence of many CD68-positive cells (Figure 3). Although Wallerian degeneration often occurs as a result of axotomy, this may be a result of neuron cell death in hSOD1-G93A mice.

DF damage in hSOD1-G93A mice occurred primarily in Region I (Figure 6), which contains largediameter myelinated axons originating in DRG (Marsala et al., 2007). This finding is consistent with damage of DRG and DR in these animals. The main bulk of large myelinated axons in the DF are responsible for transmitting discriminative touch, vibratory sensibility, position sense and proprioception. Therefore, it is of note that diminished vibration sense and/or abnormal touch-pressure sensation were also detected in a significant percentage of ALS patients (Dyck et al., 1975; Georgesco et al., 1994; Kawata et al., 1997; Matsumoto et al., 1999; Pugdahl et al., 2007). The nature of the nerve fibers in Region II is unclear, but it appeared to contain small-caliber axons and did not show significant damage in hSOD1-G93A mice (Figure 4). Region III is believed to be occupied by corticospinal tract and was not significantly affected in hSOD1-G93A mice either (Figure 6), consistent with the notion that these animals present largely a disease of spinal cord motor neurons.

Methods

Animals

Transgenic hSOD1-G93A mice and their non-transgenic normal littermates were generated by breeding male hemizygous carriers (B6SJL-Tg(SOD1-G93A)1Gur/J) to female B6SJLF1 hybrids. The transgene in B6SJL-Tg (SOD1-G93A)1Gur/J mice, which were purchased from the Jackson Laboratories (Bar Harbor, ME), carried a high copy number of hSOD1-G93A. B6SJLF1 hybrids were purchased from Beijing Vital River Experimental Animal Co (Beijing, China). PCR-based genotyping of tail/ blood DNA, as previously described (Gurney et al., 1994), was used to identify the transgenic mice and their normal littermates. The animals were housed in a room with 12 h light cycle and provided with free access to water and diet (standard diet purchased from Beijing Vital River Experimental Animal Co. Ltd, Beijing, China).

To monitor disease progression, the animals were visually inspected daily, and weighed twice a week starting 12 weeks of age. Animals were killed at several time points to obtain spinal cord tissues for analysis. They were anesthetized with 10% chloral hydrate (0.2 ml/mice) and perfused transcardially with 4% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. The spinal cords were carefully dissected. The lumbar enlargements (L3-5), as well as associated ventral root (VR), dorsal root (DR) and dorsal root ganglia (DRG) were fixed in 4% paraformaldehyde, or incubated in 4% glutaraldehyde for 24 h and then in 1% osmium tetroxide for 1 h. All experiments were carried out in accordance with the regulation of laboratory animal management promulgated by the Ministry of Science and Technology of the People's Republic of China (1988, No. 134), which conforms to the Guidelines laid down by the NIH in the US regarding the care and use of animals for experimental procedures.

Toluidine blue stain and transmission electron microscopy

Tissues after treatment with glutaraldehyde and osmium tetroxide as mentioned above were dehydrated through graded acetones and embedded in epoxy resin Epon 812. Semithin sections (1 µm) were cut, placed on the slides, and oven dried. The slides were stained with 1% toluidine blue solution for 10 min, rinsed with water, dehydrated and mounted. For transmission electron microscopy examination, ultra-thin sections (70 nm) were cut, placed on a copper grid, stained with uranyl acetate and lead citrate, and evaluated under a JEM-1230 electron microscope.

Nerve fiber teasing

VR and DR tissues fixed in 4% paraformaldehyde were treated sequentially with 1% osmimum tetroxide for 1 h, 33% glycerol for 12 h, 66% glycerol for 12 h, and stored in 100% glycerol. Single nerve fibers were isolated by teasing with dissection needles under a stereo microscope (SMZ-143, Motic). Images were recorded using a Nikon digital camera.

Naumenko-Feigin silver stain

VR and DR tissues fixed in 4% paraformaldehyde were paraffin-embedded and cut into 12 µm sections. The sections were then deparaffinized, hydrated and impregnated in 0.14% silver nitrate at 56-60℃ for 24 h. After further treatment in 2% sodium sulfate and 1% hydroquinone for 6 min, the sections were thoroughly washed in water for 15 min and then toned with 1% gold chloride for 5 min. After a brief rinse with water, the sections were treated with freshly prepared 2% oxalic acid for 10 min, followed by water rinsing again. The sections were then incubated in 5% sodium thiosulfate for 3 min and after rinsing with water placed in 0.1% Luxol Fast Blue solution at 56-60℃ overnight. The sections were rinsed with 95% ethanol to remove excess stain and further treated alternating between 0.5% lithium carbonate and 70% ethanol until individual fibers were distinguishable. Sections were then dehydrated and mounted.

Axonal counting

To quantify the number of axons, toluidine blue stained transverse semithin sections of lumbar ventral and dorsal roots were captured with Image-Pro Plus 5.0 software (Media Cybernetics Inc., Bethesda, MD) at 400× magnification. Three ventral and dorsal roots from three mice in each group were analysed. In normal nerve fibers, the axon appears as a sharply demarcated lightly stained area, with a few punctate regions representing mitochondria, surrounded by its homogenously dark myelin sheath. Nerve fibers with axonal degeneration or disappearance, or collapse and fragmentation of myelin were classified as degenerating fibers, and the data were analyzed statistically using Student's t-test.

Immunohistochemistry

Paraffin-embedded sections of VR, DR and DRG were cut at 5 µm, and free-floating sections of lumbar enlargement were cut at 20 µm. The sections were incubated in 3% H2O2 in methanol for 15 min at room temperature to block endogenous peroxidase. Non-specific antibody binding was blocked by incubating the tissues for 1 h at room temperature in a solution containing 10% serum obtained from the same species from which the secondary antibody was prepared. The sections were then incubated overnight at 4℃ with a desired antibody, including monoclonal SMI-31 (Sternberger, 1:1,000 dilution), monoclonal SMI-32 (Sternberger, 1:1,500), a monoclonal antibody against CD68 (Dako, 1:25), and a polyclonal antibody against calretinin (Santa Cruz, 1:200). The sections were subsequently incubated with a biotin-conjugated secondary antibody for 1 h at room temperature, followed by incubation with HRP-conjugated streptavidin for 1 h at room temperature and treatment with 0.03% diaminobenzidine as a chromogen for 10 min.

Statistical analysis

Results are expressed as means ± SD. Statistical analyses were performed using one-way ANOVA followed by Student's t-test. Differences were considered significant at P < 0.05.

Abbreviations

ALS

amyotrophic lateral sclerosis

DF

dorsal funiculus

DR

dorsal root

DRG

dorsal root ganglia

SOD1

superoxide dismutase 1

VR

ventral root

References

  • 1.Andersen PM. Amyotrophic lateral sclerosis genetics with Mendelian inheritance. In: Brown RH Jr, Swash M, Pasinelli P, editors. Amyotrophic lateral sclerosis. Lodon: Informa Healthcare; 2006. pp. 187–207. [Google Scholar]
  • 2.Dyck PJ, Stevens JC, Mulder DW, Espinosa RE. Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves. Neurology. 1975;25:781–785. doi: 10.1212/wnl.25.8.781. [DOI] [PubMed] [Google Scholar]
  • 3.Feeney SJ, McKelvie PA, Austin L, Jean-Francois MJ, Kapsa R, Tombs SM, Byrne E. Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:1510–1519. doi: 10.1002/mus.1176. [DOI] [PubMed] [Google Scholar]
  • 4.Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232–240. doi: 10.1016/j.expneurol.2003.10.004. [DOI] [PubMed] [Google Scholar]
  • 5.Fischer LR, Culver DG, Davis AA, Tennant P, Wang M, Coleman M, Asress S, Adalbert R, Alexander GM, Glass JD. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol Dis. 2005;19:293–300. doi: 10.1016/j.nbd.2005.01.008. [DOI] [PubMed] [Google Scholar]
  • 6.Georgesco M, Salerno A, Carlander B, Leger JJ, Camu W, Billiard M, Cadilhac J. Somatosensory evoked potentials in amyotrophic lateral sclerosis and primary lateral sclerosis. Rev Neurol (Paris) 1994;150:292–298. [PubMed] [Google Scholar]
  • 7.Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–1775. doi: 10.1126/science.8209258. [DOI] [PubMed] [Google Scholar]
  • 8.Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, et al. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. Embo J. 2003;22:6665–6674. doi: 10.1093/emboj/cdg634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Isaacs JD, Dean AF, Shaw CE, Al-Chalabi A, Mills KR, Leigh PN. Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry. 2007;78:750–753. doi: 10.1136/jnnp.2006.098798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis. 2000;7:623–643. doi: 10.1006/nbdi.2000.0299. [DOI] [PubMed] [Google Scholar]
  • 11.Kawata A, Kato S, Hayashi H, Hirai S. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci. 1997;153:82–85. doi: 10.1016/s0022-510x(97)00176-7. [DOI] [PubMed] [Google Scholar]
  • 12.Kraft AD, Resch JM, Johnson DA, Johnson JA. Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp Neurol. 2007;207:107–117. doi: 10.1016/j.expneurol.2007.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335–339. doi: 10.1126/science.288.5464.335. [DOI] [PubMed] [Google Scholar]
  • 14.Marsala J, Lukacova N, Kolesar D, Sulla I, Galik J, Marsala M. The distribution of primary nitric oxide synthase- and parvalbumin-immunoreactive afferents in the dorsal funiculus of the lumbosacral spinal cord in a dog. Cell Mol Neurobiol. 2007;27:475–504. doi: 10.1007/s10571-007-9140-6. [DOI] [PubMed] [Google Scholar]
  • 15.Matsumoto A, Kawashima A, Doi S, Moriwaka F, Tashiro K. The spinal somatosensory evoked potentials in amyotrophic lateral sclerosis in relation to the spinal cord conduction velocities. No To Shinkei. 1999;51:41–47. [PubMed] [Google Scholar]
  • 16.Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, Johnsen B, Fawcett PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry. 2007;78:746–749. doi: 10.1136/jnnp.2006.098533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
  • 18.Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA. 1995;92:3024–3028. doi: 10.1073/pnas.92.7.3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sasaki S, Horie Y, Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114:633–639. doi: 10.1007/s00401-007-0299-1. [DOI] [PubMed] [Google Scholar]
  • 20.Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci. 2002;22:6537–6548. doi: 10.1523/JNEUROSCI.22-15-06537.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA. 1996;93:3155–3160. doi: 10.1073/pnas.93.7.3155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zang DW, Cheema SS. Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett. 2002;332:99–102. doi: 10.1016/s0304-3940(02)00944-8. [DOI] [PubMed] [Google Scholar]
  • 23.Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol. 1997;139:1307–1315. doi: 10.1083/jcb.139.5.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Experimental & Molecular Medicine are provided here courtesy of Korean Society for Biochemistry and Molecular Biology

RESOURCES